ID

43889

Description

Study Part: Prior Parkinson’s Medication Screening. An open-label, up-titration study to assess the dose proportionality of ropinirole controlled release (CR) and to demonstrate the bioequivalence of ropinirole CR (1 x 8 mg) compared to the ropinirole CR (4 x 2 mg) in Parkinson's Disease patients not receiving other dopaminergic therapies. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Phase: phase 2. Study Recruitment Status: Completed. Generic Name: ropinirole. Trade Name: Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP,Zygara. Study Indication: Parkinson Disease. Study ID: 101468/165. Clinical Study ID: 101468/165

Keywords

  1. 10/16/17 10/16/17 -
  2. 9/20/21 9/20/21 -
Copyright Holder

GlaxoSmithKline

Uploaded on

September 20, 2021

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Prior Parkinson’s Medication Screening Ropinirole Parkinson Disease 101468/165

Prior Parkinson’s Medication Screening

PRIOR PARKINSON’S MEDICATION
Description

PRIOR PARKINSON’S MEDICATION

Alias
UMLS CUI-1
C0013227
UMLS CUI-2
C0030567
Patient Number
Description

Patient Number

Data type

text

Alias
UMLS CUI [1]
C1830427
Centre Number
Description

Centre Number

Data type

integer

Alias
UMLS CUI [1,1]
C0600091
UMLS CUI [1,2]
C0019994
Has the subject taken any Parkinson’s medication within 30 days PRIOR to the study?
Description

Medication Parkinson Disease

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0030567
Drug Name
Description

Drug Name

Data type

text

Alias
UMLS CUI [1]
C2360065
SINGLE Dose/Unit
Description

dose

Data type

text

Alias
UMLS CUI [1]
C3174092
Frequency of this Dose
Description

dose frequency

Data type

text

Alias
UMLS CUI [1]
C2826654
Route
Description

IA = intra-articular IAR = intra-arterial ID = intra-dermal IH = inhalation IM = intra-muscular IT = intra-thecal IV = intra-venous NA = nasal PO = oral PR = rectal SC = subcutaneous SL = sublingual TD = transdermal TO = topical VA = vaginal

Data type

text

Alias
UMLS CUI [1]
C0013153
Indication- Parkinson’s
Description

Indication

Data type

boolean

Alias
UMLS CUI [1]
C3146298
Duration of Therapy
Description

Duration of Therapy

Data type

text

Alias
UMLS CUI [1]
C0444921
End Date
Description

End Date

Data type

date

Alias
UMLS CUI [1]
C0806020
Continuing at end of study?
Description

Continuing at end of study

Data type

boolean

Alias
UMLS CUI [1]
C1553904

Similar models

Prior Parkinson’s Medication Screening

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
PRIOR PARKINSON’S MEDICATION
C0013227 (UMLS CUI-1)
C0030567 (UMLS CUI-2)
Patient Number
Item
Patient Number
text
C1830427 (UMLS CUI [1])
Centre Number
Item
Centre Number
integer
C0600091 (UMLS CUI [1,1])
C0019994 (UMLS CUI [1,2])
Medication Parkinson Disease
Item
Has the subject taken any Parkinson’s medication within 30 days PRIOR to the study?
boolean
C0013227 (UMLS CUI [1,1])
C0030567 (UMLS CUI [1,2])
Drug Name
Item
Drug Name
text
C2360065 (UMLS CUI [1])
dose
Item
SINGLE Dose/Unit
text
C3174092 (UMLS CUI [1])
dose frequency
Item
Frequency of this Dose
text
C2826654 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
Indication
Item
Indication- Parkinson’s
boolean
C3146298 (UMLS CUI [1])
Duration of Therapy
Item
Duration of Therapy
text
C0444921 (UMLS CUI [1])
End Date
Item
End Date
date
C0806020 (UMLS CUI [1])
Continuing at end of study
Item
Continuing at end of study?
boolean
C1553904 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial